The Drugs Controller General of India (DCGI) on Tuesday approved India s first indigenously developed mRNA vaccine against COVID-19 for restricted emergency use for adults.
rBIO Doubles Insulin Output Over Legacy Manufacturing Methods, Putting Company on Track to Reduce Insulin Costs by 30% - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ rBIO, an early-stage synthetic biology company focused on reducing the cost of increasingly costly biologic therapies, announced refinement of.
/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global mRNA Manufacturing and Synthesis Services Market–.